Herbal tea may soothe bladder cancer Patients' urinary woes
NCT ID NCT05739071
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether JING SI HERBAL TEA, a dietary supplement with herbal extracts, can ease lower urinary tract symptoms in bladder cancer patients who have received intravesical therapy. One hundred participants will receive either the herbal tea or a placebo, and their urinary symptoms and quality of life will be tracked. The goal is to see if this natural drink can provide relief without interfering with standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- JING SI HERBAL TEA (a dietary supplement with herbal extracts)
- What this could lead to
- If it works, this could offer a natural way to reduce urinary discomfort after bladder cancer treatment.
- What could go wrong
- This is a small, early-stage trial with no phase designation, so results may not be conclusive. The supplement may not outperform placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2023
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Clinical diagnosis bladder cancer * Under intravesical installation therapy Exclusion Criteria: * Patients under 20 years old or greater than 100 years old * Women with pregnancy or breastfeeding plans * Bladder cancer are being treated in another hospital * Had admitted due to other disease in the past 3 months * Unable to understand the questionnaire
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bladder cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Buddhist Tzu Chi General Hospital, Taipei branch
Taipei, Taiwan, 231, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dutch bladder cancer cohort aims to map survival and recurrence
- Can two drugs plus chemoradiation let bladder cancer patients keep their bladder?
- Lab-Grown tumor organoids could pick the right bladder chemo
- Can tumor genes decide who keeps their bladder?
- Lab-Grown tumor models could match patients to the right cancer drug
- Can heated saline during bladder surgery stop tumors from coming back?